App Store

Google Play

image.devices-Singapore 2x

Step into an infinite world of stories

Listen and read

This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.
Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.
The sixth volume of this series features 6 chapters that cover the following topics:
- Alternative anti-infective / anti-inflammatory therapeutic options for fighting Alzheimer’s disease
- Microbial peptides that combat microbial biofilms 
- Malaria and its treatment
- Tuberculosis drugs
… and much more.

Bentham Science

Frontiers in Anti-Infective Drug Discovery

Frontiers in Anti-Infective Drug Discovery: Volume 6

Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The seventh volume of the book features reviews on these topics:

· Essential oils and monoterpenes as potential anti-cancer agents

· Drug delivery systems and emerging immunotherapeutic strategies for the treatment of glioblastoma

· CTDNA in solid tumors

· Cholesterol treatments (including Pitavastatin) and their potential in cancer treatment

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 7

This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal ch

Frontiers in Anti-Infective Drug Discovery: Volume 7

This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.

Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.

The eighth volume of this series features 8 chapters that cover methods for antimicrobial drug discovery (with 2 chapters that focus on genomics) as well as updates on drug development against Helicobacter pylori and emerging coronaviruses, among other interesting topics:

- Eradication of Helicobacter pylori Infection with Non-Bismuth Quadruple Concomitant Therapy

- Drug Discovery Strategies Against Emerging Coronaviruses: A Global Threat

- Opportunities Offered By Fragment-Based Drug Design in Antibiotic Development

- Phage therapy as a Tool for Control of Foodborne Diseases: Advantages and Limitations

- Subtractive Genomics Approaches: Towards Anti-Bacterial Drug Discovery

- Recent Advances in the Discovery of Antimicrobials through Metagenomics

- Phyto-Nano-Antimicrobials: Synthesis, Characterization, Discovery, and Advances

- Aptamers as Anti-infective Agents

Frontiers in Anti-Infective Drug Discovery: Volume 8

This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.

Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.

The ninth volume of this series features 5 reviews that cover some aspects of clinical and pre-clinical antimicrobial drug development, with 2 chapters focusing on drugs to treat leishmaniasis and dengue fever, respectively.

- Use of preclinical and early clinical data for accelerating antimicrobial drug development

- Post-translational modifications: host defence mechanism, pathogenic weapon, and emerged target of anti-infective drugs

- Scope and limitations on the potent antimicrobial activities of hydrazone derivatives

- Current scenario of anti-leishmanial drugs and treatment

- Dengue hemorrhagic fever: the potential repurposing drugs